XML 60 R22.htm IDEA: XBRL DOCUMENT v2.4.0.6
Available-for-Sale Investments (Table Text Block)
9 Months Ended
Dec. 31, 2012
Investments, Debt and Equity Securities [Abstract]  
Available-for-sale securities
Available-for-sale investments at December 31, 2012 were as follows:
 
 
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses More than 12 Months
 
Gross
Unrealized
Losses Less than 12 Months
 
Estimated
Market
Value
 
 
(Unaudited)
 
 
(In thousands)
U.S. treasury securities and government obligations
$
21,201
$
2,910
$
(3
)
-
$
24,108
U.S. government agency mortgage-backed securities
 
41,010
 
4,427
 
(7
)
(1
)
45,429
Obligations of states and political subdivisions
 
149,644
 
16,073
 
(2
)
(54
)
165,661
Corporate securities
 
662,087
 
52,067
 
(650
)
(1,131
)
712,373
Mortgage-backed securities
 
24,597
 
774
 
(25
)
(30
)
25,316
Redeemable preferred stocks
 
21,353
 
1,208
 
(342
)
(11
)
22,208
Common stocks
 
30,866
 
99
 
(6,092
)
-
 
24,873
 
$
950,758
$
77,558
$
(7,121
)
(1,227
)
1,019,968
 
The table above includes gross unrealized losses that are not deemed to be other-than-temporarily impaired, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position.
We sold available-for-sale securities with a fair value of $90.7 million during the first nine months of fiscal 2013. The gross realized gains on these sales totaled $1.9 million. The gross realized losses on these sales totaled $0.6 million.
The unrealized losses of more than twelve months in the available-for-sale table are considered temporary declines. The majority of this unrealized loss is related to our long term investments in 1.8 million shares of Bank of America common stock. We track each investment with an unrealized loss and evaluate them on an individual basis for other-than-temporary impairments including obtaining corroborating opinions from third party sources, performing trend analysis and reviewing management's future plans. Certain of these investments may have declines determined by management to be other-than-temporary and we recognized these write-downs through earnings. Our insurance subsidiaries recognized $0.1 million in other-than-temporary impairments for the first nine months of fiscal 2012. There were no write downs in the third quarter of fiscal 2013 and 2012 or for the first nine months of fiscal 2013.